Pharmacia Corp. v. Par Pharmaceutical, Inc.
Court of Appeals for the Federal Circuit
1Opinion of the Court
RADER, Circuit Judge.
Par Pharmaceutical, Inc. (Par) filed Abbreviated New Drug Application (ANDA) No. 76-218, seeking approval to market and sell a generic version of a glaucoma medication called Xalatan. Because the United States District Court for the District of New Jersey did not abuse its discretion in finding only U.S. Patent No. 5,422,368 (the ’368 patent) unenforceable due to inequitable conduct, this court affirms.
I
Glaucoma is a chronic disease manifested by an increased fluid pressure in the eye, known as intraocular pressure. Treatments include topical medications, oral medications…
2Cases cited8 opinions
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
- Molins Plc, and John Coventry Smith, Jr. v. Textron, Inc., Kearney & Trecker Corporation, and Avco CorporationCourt of Appeals for the Federal Circuit · 1995
- Critikon, Inc., Plaintiff-Cross v. Becton Dickinson Vascular Access, Inc.Court of Appeals for the Federal Circuit · 1997
- Hewlett-Packard Company, Plaintiff/cross-Appellant v. Bausch & Lomb IncorporatedCourt of Appeals for the Federal Circuit · 1989
3 more not listed; retrieve them via the Exa API.
3Cited by28 opinions
- Innogenetics, N v. v. Abbott LaboratoriesCourt of Appeals for the Federal Circuit · 2008
- Ferring B v. & Aventis Pharmaceuticals, Inc. v. Barr Laboratories, Inc.Court of Appeals for the Federal Circuit · 2006
- Golden Hour Data Systems, Inc. v. emsCharts, Inc.Court of Appeals for the Federal Circuit · 2010
- eSpeed, Inc. v. Brokertec USA, L.L.C.Court of Appeals for the Federal Circuit · 2007
- Therasense, Inc. v. Becton, Dickinson and Co.Court of Appeals for the Federal Circuit · 2010
23 more not listed; retrieve them via the Exa API.